New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Future Oncology

• Publication date

  2010-04-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2217/fon.10.21PMID 20373867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of microRNA in anticancer drug resistance

  2010cited by this paper
• Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

  2009cited by this paper
• Reversal of P‐glycoprotein‐mediated multi‐drug resistance by the E3 ubiquitin ligase Cbl‐b in human gastric adenocarcinoma cells

  2009cited by this paper
• Meta‐analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

  2009cited by this paper
• Optimising treatment regimens for the management of advanced gastric cancer.

  2009cited by this paper
• Epidemiology of stomach cancer.

  2009cited by this paper
• Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44

  2009cited by this paper
• Gastric cancer in the era of molecularly targeted agents: current drug development strategies

  2009cited by this paper
• Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC).

  2009cited by this paper
• Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines.

  2009cited by this paper
• Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.

  2009cited by this paper
• Hypoxia‐mediated up‐regulation of MGr1‐Ag/37LRP in gastric cancers occurs via hypoxia‐inducible‐factor 1‐dependent mechanism and contributes to drug resistance

  2009cited by this paper
• Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours.

  2009cited by this paper
• Surgery and adjuvant chemotherapy

  2008cited by this paper
• Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer

  2008cited by this paper
• miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

  2008cited by this paper
• The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.

  2008cited by this paper
• MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

  2008cited by this paper
• Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin.

  2008cited by this paper
• MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN (Cancer Research (2008) 68, (425-433))

  2008cited by this paper
• Expression of Multidrug Resistance-Related Proteins p-Glycoproteinglutathione-s-Transferases, Topoisomerase-II and Lung Resistance Protein in Primary Gastric Cardiac Adenocarcinoma

  2008cited by this paper
• A subcelluar proteomic investigation into vincristine‐resistant gastric cancer cell line

  2008cited by this paper
• Chemotherapy in gastric cancer.

  2008cited by this paper
• Gastric cancer: pathogenesis, screening, and treatment.

  2008cited by this paper
• Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase

  2008cited by this paper
• MicroRNAs modulate the chemosensitivity of tumor cells

  2008cited by this paper
• Prediction of doxorubicin sensitivity in gastric cancers based on a set of novel markers.

  2008cited by this paper
• Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death

  2008cited by this paper
• Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.

  2008cited by this paper
• Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy

  2007cited by this paper
• Hypoxia‐inducible factor‐1α contributes to hypoxia‐induced chemoresistance in gastric cancer

  2007cited by this paper
• Antitumor effects and drug interactions of the proteasome inhibitor bortezomib (PS341) in gastric cancer cells

  2007cited by this paper
• Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax.

  2007cited by this paper
• Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil

  2007cited by this paper
• Phase II of trastuzumab and cisplatin in patients (pts) with advanced gastric cancer (AGC) with HER2/neu overexpression/amplification

  2007cited by this paper
• Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).

  2007cited by this paper
• Hypoxia induced overexpression of PrPC in gastric cancer cell lines

  2007cited by this paper
• TRF2 promotes multidrug resistance in gastric cancer cells

  2006cited by this paper
• Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel

  2006cited by this paper
• Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• Proteome analysis of multidrug resistance in vincristine‐resistant human gastric cancer cell line SGC7901/VCR

  2006cited by this paper
• Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma.

  2006cited by this paper
• Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

  2006cited by this paper
• Glutathione-related systems and modulation of extracellular signal-regulated kinases are involved in the resistance of AGS adenocarcinoma gastric cells to diallyl disulfide-induced apoptosis.

  2005cited by this paper
• Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer

  2005cited by this paper
• Preoperative and adjuvant therapies for upper gastrointestinal cancers

  2005cited by this paper
• Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model.

  2005cited by this paper
• The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

  2005cited by this paper
• Mechanisms of Disease: PI3K/AKT Signaling in Gastrointestinal Cancers

  2005cited by this paper
• Is the hypoxia-inducible factor pathway important in gastric cancer?

  2005cited by this paper
• Increased Expression of Metallothionein Is Associated with Irinotecan Resistance in Gastric Cancer

  2004cited by this paper
• Effects of Paclitaxel and Docetaxel on EGFR-Expressing Human Carcinoma Cells Under Normoxic Versus Hypoxic Conditions In Vitro

  2004cited by this paper
• Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.

  2004cited by this paper
• Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays

  2004cited by this paper
• Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes

  2004cited by this paper
• Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells

  2003cited by this paper
• Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study

  2003cited by this paper
• Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.

  2003cited by this paper
• Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

  2002cited by this paper
• Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells.

  2002cited by this paper
• Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

  2001cited by this paper
• Expression of multidrug resistance-related markers in gastric cancer.

  2000cited by this paper
• Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.

  2000cited by this paper
• Glutathione S-transferases and iododeoxyuridine labelling index during chemotherapy of gastric cancer.

  2000cited by this paper
• Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer

  1999cited by this paper
• Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy.

  1999cited by this paper
• High Expression of Multidrug Resistance-1 (MDR-1) and its Relationship with Multiple Prognostic Factors in Gastric Carcinomas in Patients in Turkey

  1999cited by this paper
• Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

  1999cited by this paper
• Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line

  1998cited by this paper
• Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers.

  1998cited by this paper
• Intrapleural administration of interleukin‐2 for the treatment of patients with malignant pleural mesothelioma

  1998cited by this paper
• Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma

  1998cited by this paper
• Decreased drug accumulation in a mitoxantrone‐resistant gastric carcinoma cell line in the absence of P‐glycoprotein

  1997cited by this paper
• Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer.

  1997cited by this paper
• Characteristics of human gastric carcinoma cell lines with induced multidrug resistance.

  1997cited by this paper
• Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.

  1996cited by this paper
• The Multidrug Resistance‐associated Protein Gene Confers Drug Resistance in Human Gastric and Colon Cancers

  1996cited by this paper
• Expression of multidrug‐resistance‐associated protein (MRP) and chemosensitivity in human gastric cancer

  1996cited by this paper
• Establishment and characterization of human gastric and colonic xenograft lines resistant to CPT‐11 (A new derivative of camptothecin)

  1995cited by this paper
• Expression of π-glutathione S-transferase gene (GSTP1) in gastric cancer: Lack of correlation with resistance against cis-diamminedichloroplatinum (II)

  1994cited by this paper
• Expression of pi-glutathione S-transferase gene (GSTP1) in gastric cancer: lack of correlation with resistance against cis-diamminedichloroplatinum (II).

  1994cited by this paper
• Expression of glutathione s‐transferasepi and sensitivity of human gastric cancer cells to cisplatin

  1994cited by this paper
• MDR1 gene expression and its clinical relevance in primary gastric carcinomas

  1993cited by this paper
• Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining.

  1992cited by this paper
• Expression of MDR1 and glutatione S transferase‐π genes and chemosensitivities in human gastrointestinal cancer

  1992cited by this paper
• Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors.

  1990cited by this paper
• Serum glutathione‐s‐transferase‐π as a tumor marker for gastrointestinal malignancies

  1989cited by this paper

• H2valdien3 arrests the cell cycle and induces apoptosis of gastric cancer

  2025cites this paper
• Helicobacter pylori CagA protein confers aggressive phenotypes to gastric cancer cells through the HIF-1α-mediated metabolic reprogramming

  2025cites this paper
• Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival

  2025cites this paper
• Targeted Radionuclide Therapy of CLDN18.2-Positive Gastric Cancer with [131I]I-Zolbetuximab: An In Vitro and In Vivo Study.

  2025cites this paper
• Clinical Analysis of Multidrug Resistance-Related Protein Expression in Gastric Cancer Cells

  2024cites this paper
• MicroRNA-98: the multifaceted regulator in human cancer progression and therapy

  2024cites this paper
• Critical role of miR-21/exosomal miR-21 in autophagy pathway.

  2024cites this paper
• Artificial intelligence in theranostics of gastric cancer, a review

  2023cites this paper
• The importance of hsa-miR-28 in human malignancies.

  2023cites this paper
• Oleanolic acid increases the anticancer potency of doxorubicin in pancreatic cancer cells

  2023cites this paper
• Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer

  2022cites this paper
• Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance

  2022cites this paper
• Pteroyl-γ-l-glutamate/Pluronic® F68 modified polymeric micelles loaded with docetaxel for targeted delivery and reduced toxicity

  2022cites this paper
• Wharton jelly stem cells inhibits AGS gastric cancer cells through induction of apoptosis and modification of MAPK and NF-κB signaling pathways.

  2021cites this paper
• hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression

  2021cites this paper
• Ethyl acetate extract of Elephantopus mollis Kunth induces apoptosis in human gastric cancer cells

  2021cites this paper
• Silencing of the ARK5 gene reverses the drug resistance of multidrug-resistant SGC7901/DDP gastric cancer cells

  2020cites this paper
• GRP78 targeting: Hitting two birds with a stone

  2020cites this paper
• Pivotal Role of Peptides in Gastric Carcinoma: Diagnosis and Therapy

  2020cites this paper
• Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines

  2020cites this paper
• Exosomal MiR‐500a‐3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer

  2020cites this paper
• Pivotal Role of Peptides in Gastric Carcinoma: Diagnosis and Therapy

  2020cites this paper
• Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma

  2020cites this paper
• Melatonin increases the anticancer potential of doxorubicin in Caco‐2 colorectal cancer cells

  2020cites this paper
• Salvianolic acid B suppresses EMT and apoptosis to lessen drug resistance through AKT/mTOR in gastric cancer cells

  2020cites this paper
• Exosomal Transfer of MiR-500a-3p Confers Cisplatin Resistance and Stemness via Targeting FBXW7 in Gastric Cancer

  2020cites this paper
• The effect of omega fatty acids oral administration on apoptotic regulatory proteins in patients with gastric adenocarcinoma under chemotherapy-A double blind clinical trial study

  2020cites this paper
• DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.

  2020cites this paper
• Bioinformatics analysis identifies potential chemoresistance-associated genes across multiple types of cancer.

  2019cites this paper
• miR-1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells

  2019cites this paper
• An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets

  2019cites this paper
• Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics.

  2019cites this paper
• CMAR_A_208708 6615..6624

  2019cites this paper
• DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2.

  2019cites this paper
• miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1

  2019cites this paper
• Tailoring the Chemical Modification of Chitosan Hydrogels to Fine Tune the Release of a Synergistic Combination of Chemotherapeutics.

  2019cites this paper
• Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.

  2018cites this paper
• Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer

  2018cites this paper
• [Chinese herbal medicine Euphorbia esula extract induces apoptosis and inhibits the proliferation, migration and invasion of multidrug resistant gastric carcinoma cells].

  2018cites this paper
• Euphorbia lunulata extract acts on multidrug resistant gastric cancer cells to inhibit cell proliferation, migration and invasion, arrest cell cycle progression, and induce apoptosis.

  2018cites this paper
• Is co-expression of USP22 and HSP90 more effective in predicting prognosis of gastric cancer?

  2018cites this paper
• MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression

  2017cites this paper
• JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells

  2017cites this paper
• Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers

  2017cites this paper
• Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis.

  2017cites this paper
• Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells

  2017cites this paper
• AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway

  2017cites this paper
• Strategy to enhance efficacy of doxorubicin by curcumin as a potent Pgp inhibitor in gastric cancer

  2017cites this paper
• MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell

  2017cites this paper
• Multifunctional Nanoprobes for Theranostics of Gastric Cancer

  2017cites this paper
• Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer

  2016cites this paper
• FAT4 hypermethylation and grade dependent downregulation in gastric adenocarcinoma

  2016cites this paper
• Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer

  2016cites this paper
• MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT).

  2016cites this paper
• MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells

  2016cites this paper
• Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition

  2016cites this paper
• HNRNPC as a candidate biomarker for chemoresistance in gastric cancer

  2016cites this paper
• Mechanisms of Resistance to Chemotherapy in Gastric Cancer.

  2016cites this paper
• Programmed death 1 induces cell chemoresistance to 5-fluorouracil in gastric cancer cell lines

  2016cites this paper
• Advance and Prospects of Nanotheranostic Technology for Gastric Cancer

  2016cites this paper
• Human CIK Cells Loaded with Gold Nanoprisms as Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immuno-Photothermal Combined Therapy

  2016cites this paper
• EGFR Antibody Conjugated Bimetallic Au@Ag Nanorods for Enhanced SERS-Based Tumor Boundary Identification, Targeted Photoacoustic Imaging and Photothermal Therapy

  2016cites this paper
• Multifunctional Nanoprobes for Multimodality Targeted Imaging and Therapy of Gastric Cancer

  2016cites this paper
• Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA

  2015cites this paper
• Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes

  2015cites this paper
• siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.

  2015cites this paper
• In vitro Anti-Gastric Tumor Activities and Possible Mechanisms of Action of Paederosidic Acid from Paederia scandens (Lour) Merrill

  2015cites this paper
• Hypoxia and hypoxia inducible factors in tumor metabolism.

  2015cites this paper
• MicroRNA-induced drug resistance in gastric cancer.

  2015cites this paper
• siRNA Silencing EZH 2 Reverses Cisplatin-resistance of Human Non-small Cell Lung and Gastric Cancer Cells

  2015cites this paper
• CD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells

  2015cites this paper
• High glucose promotes gastric cancer chemoresistance in vivo and in vitro

  2015cites this paper
• [Corrigendum] High expression of RELM-α correlates with poor prognosis and promotes angiogenesis in gastric cancer

  2015influential citation
• Biased random walk model for the prioritization of drug resistance associated proteins

  2015cites this paper
• RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells

  2015cites this paper
• Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis

  2015cites this paper
• Upregulation of Autophagy-Related Gene-5 (ATG-5) Is Associated with Chemoresistance in Human Gastric Cancer

  2014cites this paper
• Alteration of gene expression and DNA methylation in drug-resistant gastric cancer.

  2014cites this paper
• Mechanism of bFGF-binding Peptide Reversing Adriamycin Resistance in Human Gastric Cancer Cells

  2014cites this paper
• In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model.

  2014cites this paper
• ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells in vitro and its real-time evaluation by bioluminescence imaging in vivo.

  2013cites this paper
• A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells.

  2013cites this paper
• Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway

  2013cites this paper
• CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2

  2013cites this paper
• Anti-cancer activity of DHA on gastric cancer—an in vitro and in vivo study

  2013cites this paper
• WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer.

  2013cites this paper
• ABCC1 Is Related to the Protection of the Distal Nephron against Hyperosmolality and High Sodium Environment: Possible Implications for Cancer Chemotherapy

  2013cites this paper
• Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes

  2013cites this paper
• In-depth research of multidrug resistance related cell surface glycoproteome in gastric cancer.

  2013cites this paper
• High level of serum AMBP is associated with poor response to paclitaxel–capecitabine chemotherapy in advanced gastric cancer patients

  2013cites this paper
• Partial Purification of Cytotoxic Peptides against Gastric Cancer Cells from Protein Hydrolysate of Euphorbia hirta Linn.

  2013cites this paper
• Fibroblast growth factor receptor 2: a therapeutic target in gastric cancer

  2013cites this paper
• Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population

  2013cites this paper
• Discovery of the Inhibitory Effect of a Phosphatidylinositol Derivative on P-Glycoprotein by Virtual Screening Followed by In Vitro Cellular Studies

  2013cites this paper
• Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells through Transactivation of SIRT1 Expression

  2012cites this paper
• Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells.

  2012cites this paper
• Drug Efflux Transporters and Multidrug Resistance in Acute Leukemia: Therapeutic Impact and Novel Approaches to Mediation

  2012cites this paper
• Effects of 3β-Acethyl Tormentic Acid (3ATA) on ABCC Proteins Activity

  2012cites this paper
• BASIC AND TRANSLATIONAL — ALIMENTARY TRACT Pan-Histone Deacetylase Inhibitor Panobinostat Sensitizes Gastric Cancer Cells to Anthracyclines via Induction of CITED 2

  2012cites this paper
• 3β-Acetyl Tormentic Acid (3ATA) a Novel Modulator of ABCC Proteins Activity

  2012cites this paper